Page last updated: 2024-09-04

olmesartan and lisinopril

olmesartan has been researched along with lisinopril in 3 studies

Compound Research Comparison

Studies
(olmesartan)
Trials
(olmesartan)
Recent Studies (post-2010)
(olmesartan)
Studies
(lisinopril)
Trials
(lisinopril)
Recent Studies (post-2010) (lisinopril)
8411855542,210648491

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)lisinopril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.0021
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.287
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0012
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.0012

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Gold, KA; Gomez, DR; Levy, LB; Liao, Z; Nguyen, QN; O'Reilly, M; Wang, H; Xu, T; Zhuang, Y1

Other Studies

3 other study(ies) available for olmesartan and lisinopril

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.
    International journal of radiation oncology, biology, physics, 2013, Dec-01, Volume: 87, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Non-Small-Cell Lung; Female; Humans; Imidazoles; Lisinopril; Lung; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Radiation Pneumonitis; Retrospective Studies; Risk; Sex Factors; Tetrazoles; Valine; Valsartan

2013